双龙戏珠!辉瑞VS诺和诺德之争?

药事纵横
Nov 12, 2025

有钱,真可以为所欲为?2025年11月8日,全球医药圈和资本圈同步沸腾——生物科技公司Metsera官网官宣,与辉瑞达成最终合并协议修正案,辉瑞以每股65.60美元现金+最高20.65美元或有价值权(CVR)完成收购,总估值最高达86.25美元/股,整体交易规模锁定90亿美元,预计11月13日股东大会后正式交割。图1美国生物制药企业Metsera当地时间11月7日公告称,已与辉瑞公司达成修订后的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10